Novel drugs are not discovered simply by pursuing so-called “me too” targets. It is clear the ubiquitin pathway plays a fundamental role in a litany of cell physiologies; it is no wonder, then, that so many ubiquitin pathway genes are associated with or mutated in different human diseases.

We are pleased to announce the third-annual premier conference in the ubiquitin field: the 2011 Ubiquitin Drug Discovery & Diagnostics Conference, to be held at the Four Seasons Hotel in Philadelphia from July 11th to 13th. Building on the highly-successful 2009 and 2010 conferences, this year’s event will host an exciting cast of ubiquitin-focused distinguished faculty from the academic, pharmaceutical, biotech and business communities. You will have the opportunity to network and collaborate with worldwide experts in the field, and to participate in a series of interactive workshops and poster sessions. The 2011 program will focus on advances and opportunities in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting.

Already, the Ubiquitin Drug Discovery & Diagnostics conference has become a tradition where true innovation in science and medicine takes place. Please visit our website to register and reserve your place at this cutting-edge event.